ethambutol has been researched along with Colitis Gravis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Eder, IB; Kunz, M; Simon, JC; Zimmerlich, S | 1 |
Actis, G; Alberico, G; Genovesio, L; Goitre, M; Mele, M; Molinaro, GC; Puiatti, P; Salvai, M | 1 |
Celle, G; Gesu, GP; Picciotto, A; Schito, GC; Testa, R; Varagona, G | 1 |
3 other study(ies) available for ethambutol and Colitis Gravis
Article | Year |
---|---|
Mycobacterium marinum infection in an immunocompromised patient with infliximab.
Topics: Anti-Inflammatory Agents; Clarithromycin; Colitis, Ulcerative; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Infliximab; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2020 |
Cutaneous tuberculosis: atypical skin lesions in immunodepressed patients.
Topics: Adult; Colitis, Ulcerative; Ethambutol; Humans; Isoniazid; Prednisone; Rifampin; Sulfasalazine; Tuberculosis, Cutaneous; Tuberculosis, Pulmonary | 1990 |
Antimycobacterial chemotherapy in inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Ethambutol; Female; Humans; Isoniazid; Male; Mycobacterium; Rifampin; Sulfasalazine | 1989 |